NF refers to genetic conditions that cause tumors to grow on nerves throughout the body. NF includes all forms of neurofibromatosis and schwannomatosis and affects about 4 million people worldwide. Anyone can be born with NF, and it affects everyone differently. There is no cure yet.
2
FDA-approved drugs for NF, and more are being researched
Koselugo (selumetinib) and Gomekli (mirdametinib) are the only FDA-approved drugs for NF1. CTF-funded research paved the way for these approvals.
3X
the number of NF clinical trials in the past 10 years
There are currently 67 active clinical trials for NF – three times the number of trials than just ten years ago!
47
years of funding NF research
The Children’s Tumor Foundation was founded nearly 50 years ago as the first grassroots organization to support patients with all types of NF.
11,000
have joined the NF Registry
The NF Registry is a secure website where people with NF can take an active role in the search for better treatments.
20,000
patients each year visit the NF Clinic Network
The NF Clinic Network (NFCN) is the first nationwide network focused on enhancing clinical care and best practices for NF treatment.
By bringing together patients, doctors, scientists, and pharma, we drive treatments, advance care, and deliver faster results for millions affected by neurofibromatosis or schwannomatosis. Our patient-first collaborative approach accelerates drug development and brings life-changing therapies to patients faster – driven by our mission to end NF.
Our Impact
Every Gift Matters
When you become a monthly CTF supporter, your contribution can go further toward drug discovery and treatments for NF patients and their families. Please consider a one-time gift if you are not able to make a monthly commitment.
